UBS Group
SLGCW

UBS Group’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

UBS Group’s Portfolio SLGCW Stock Details SLGCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-317
Closed -$38 – 10434
2023
Q4 		$38 Sell
317
-7,618
-96% -$1.09K ﹤0.01% 9022
2023
Q3 		$1.75K Buy
+7,935
New +$1.95K ﹤0.01% 7841
2023
Q2 		– Sell
-293
Closed -$74 – 10061
2023
Q1 		$74 Sell
293
-315
-52% -$139 ﹤0.01% 9285
2022
Q4 		$243 Buy
+608
New +$242 ﹤0.01% 10286
2022
Q2 		– Sell
-634
Closed -$1K – 11267
2022
Q1 		$1K Sell
634
-132
-17% -$320 ﹤0.01% 10012
2021
Q4 		$3K Buy
766
+393
+105% +$1.5K ﹤0.01% 9723
2021
Q3 		$1K Buy
373
+330
+767% +$1.02K ﹤0.01% 9306
2021
Q2 		$0 Buy
+43
New +$222 ﹤0.01% 9987

Other funds holding SLGCW

GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS Group's SLGCW Position: Q1 2024 in Review

UBS Group sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 317 shares — an estimated $38 sold.

UBS Group first reported a position in SLGCW in Q2 2021 and held it in 8 quarters. The position peaked at $3K in Q4 2021. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

  • UBS Group reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 317 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $38.
  • UBS Group first reported a position in SomaLogic, Inc. Warrant in Q2 2021 and held it in 8 quarters.
  • UBS Group's SomaLogic, Inc. Warrant position peaked at $3K in Q4 2021.
  • 4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.